Back
Immuneering Stock Price Chart
Sponsored
IMRX
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
84
IMRX
Immuneering
Last Price:
3.19
Seasonality Move:
-30.59%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing slight buying pressure.
Immuneering Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.29 | Buy |
20-day SMA: | 1.61 | Buy |
50-day SMA: | 1.34 | Buy |
200-day SMA: | 3.28 | Sell |
8-day EMA: | 2.36 | Buy |
20-day EMA: | 1.84 | Buy |
50-day EMA: | 1.54 | Buy |
200-day EMA: | 3.04 | Buy |
Immuneering Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 77.25 | Buy |
Chaikin Money Flow: | 11044620 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.85 - 2.15) | Buy |
Bollinger Bands (100): | (1.03 - 1.75) | Buy |
Immuneering Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Immuneering Stock
Is Immuneering Stock a Buy?
- Immuneering share price is 3.19 while IMRX 8-day simple moving average is 2.29, which is a Buy signal.
- The stock price of IMRX is 3.19 while Immuneering 20-day SMA is 1.61, which makes it a Buy.
- Immuneering 50-day simple moving average is 1.34 while IMRX share price is 3.19, making it a Buy technically.
- IMRX stock price is 3.19 and Immuneering 200-day simple moving average is 3.28, creating a Sell signal.
IMRX Technical Analysis vs Fundamental Analysis
Buy
84
Immuneering (IMRX)
is a Buy
Is Immuneering a Buy or a Sell?
-
Immuneering stock is rated a Buy
The current Immuneering [IMRX] share price is $3.19. The Score for IMRX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Immuneering Stock Info
Market Cap:
94.62M
Price in USD:
3.19
Share Volume:
24.81M
Immuneering 52-Week Range
52-Week High:
9.00
52-Week Low:
1.00
Buy
84
Immuneering (IMRX)
is a Buy
Immuneering Share Price Forecast
-
What is the Immuneering stock price today?
The Immuneering stock price is 3.19 USD today. -
Will IMRX stock go up or go down?
Immuneering> share price is forecast to RISE/FALL based on technical indicators -
Is Immuneering overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immuneering is not overvalued.
Is Immuneering Stock a Buy?
- Immuneering share price is 3.19 while IMRX 8-day exponential moving average is 2.36, which is a Buy signal.
- The stock price of IMRX is 3.19 while Immuneering 20-day EMA is 1.84, which makes it a Buy.
- Immuneering 50-day exponential moving average is 1.54 while IMRX share price is 3.19, making it a Buy technically.
- IMRX stock price is 3.19 and Immuneering 200-day simple moving average is 3.04, creating a Buy signal.
Fundamental Analysis of Immuneering
Is Immuneering a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.17 per share, an increase this year of $0.01 per share, and an increase next year of $0.20 per share.
Technical Analysis of Immuneering
Should I short Immuneering stock?
- IMRX Moving Average Covergence Divergence (MACD) indicator is 0.41, suggesting Immuneering is a Buy
- Immuneering Relative Strength Index (RSI) is 77.25, which suggest Immuneering is overbought
- The Bollinger Bands (25) for Immuneering is (0.85 - 2.15), which suggest Immuneering is a Buy
- The Bollinger Bands (100) for Immuneering is (1.03 - 1.75), which suggest Immuneering is a Buy
* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.